SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Cantor Fitzgerald & Co., 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at [email protected]; and RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey ...
or RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, New York, New York 10281, by telephone at 877-822-4089 or by email at [email protected]. Smart Investor ...
Aardvark Therapeutics, Inc. ("Aardvark") (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
by telephone at 800-248-8863 or by email at [email protected]; or RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, New York, New York 10281, by telephone at 877-822-4089 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback